New therapeutics against SARS–CoV-2: Analysing small molecule chemical libraries by establishing targeted cell-based assays for inhibitors of viral entry and viral protease | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

New therapeutics against SARS–CoV-2: Analysing small molecule chemical libraries by establishing targeted cell-based assays for inhibitors of viral entry and viral protease

Implementing Organization

Rajiv Gandhi Centre for Biotechnology (RGCB)

Principal Investigator

Dr E Sreekumar

Scientist

|

Rajiv Gandhi Centre for Biotechnology (RGCB)

About

The study aims to develop cell-based assays to identify inhibitors of SARS-CoV-2 entry and also inhibitors of viral protease. It also plans to screen derivatives of Arbidol as virus entry inhibitors.

Patents

NA

Achievements

NA

Outcome / Output

NA

Publications

NA

Related Research

Funding Organization

Funding Organization

Department of Biotechnology (DBT)

Quick Information

Focus Area

Therapeutics for SARS-Cov-2

Start Year

2020

Sanction Amount

₹ NA

Status

Ongoing

Contact

esreekumar@rgcb.res.in

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

NA

No. of Patents

Filed : 00

Grant : 00